Scott D. Ramsey

Active 1994–2025

129
Papers
22,956
Citations
82
h-index
125
i10-index

Citations

Citations per year for Scott D. Ramsey1943: 1 citations1980: 1 citations1993: 1 citations1994: 1 citations1995: 3 citations1996: 1 citations1997: 6 citations1998: 13 citations1999: 13 citations2000: 26 citations2001: 38 citations2002: 67 citations2003: 98 citations2004: 116 citations2005: 174 citations2006: 134 citations2007: 141 citations2008: 169 citations2009: 138 citations2010: 166 citations2011: 130 citations2012: 142 citations2013: 154 citations2014: 173 citations2015: 189 citations2016: 173 citations2017: 175 citations2018: 186 citations2019: 623 citations2020: 592 citations2021: 600 citations2022: 473 citations2023: 307 citations2024: 544 citations2025: 200 citations2026: 2 citations1944–1979: no citations, so these years are not shown1981–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,040 citing papers, 34.8% of this breakdownUnited Kingdom: 710 citing papers, 8.1% of this breakdownCanada: 464 citing papers, 5.3% of this breakdownChina: 385 citing papers, 4.4% of this breakdownItaly: 316 citing papers, 3.6% of this breakdownAustralia: 314 citing papers, 3.6% of this breakdownGermany: 314 citing papers, 3.6% of this breakdownNetherlands: 303 citing papers, 3.5% of this breakdownFrance: 226 citing papers, 2.6% of this breakdownSpain: 200 citing papers, 2.3% of this breakdownSwitzerland: 163 citing papers, 1.9% of this breakdownJapan: 131 citing papers, 1.5% of this breakdown
0%34.8%Other 24.8%

Fields

  • Medicine66%
  • Economics, Econometrics and Finance10.9%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Health Professions3.5%
  • Neuroscience1.5%
  • Engineering1.1%
  • Other6.8%

Topics

  • Genetic factors in colorectal cancer4.4%
  • Economic and Financial Impacts of Cancer3.8%
  • Health Systems, Economic Evaluations, Quality of Life3.1%
  • Colorectal Cancer Screening and Detection2.7%
  • Cancer Genomics and Diagnostics2.5%
  • Global Cancer Incidence and Screening2.4%
  • Other81.1%

Coauthors

All papers

Open in search
  1. Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2004 cited by 3,183

  2. Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer

    Authors: , , , , , , - Journal of Clinical Oncology 2016 cited by 903

  3. Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

    Authors: , , , , , , , - Value in Health 2015 cited by 837

  4. Value and affordability of CAR T-cell therapy in the United States

    Authors: , , , , - Bone Marrow Transplantation 2020 cited by 134

  5. Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions

    Authors: , , - Journal of Clinical Oncology 2023 cited by 108

  6. Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis

    Authors: , , , , , , , , - Health Affairs 2013 cited by 687

  7. The case for early detection

    Authors: , , , , , , , , - Nature reviews. Cancer 2003 cited by 1,147

  8. Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials

    Authors: , , , , , - JAMA Network Open 2018 cited by 206

  9. Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials

    Authors: , , , , , , - Journal of Clinical Oncology 2021 cited by 145

  10. Patient Income Level and Cancer Clinical Trial Participation

    Authors: , , , , - JAMA Oncology 2015 cited by 203

  11. Pilot Feasibility Study of an Oncology Financial Navigation Program

    Authors: , , , , , , , , , , , , - Journal of Oncology Practice 2017 cited by 207

  12. A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers

    Authors: , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2020 cited by 88

  13. Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2020 cited by 167

  14. Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials

    Authors: , , , , - Cancer Epidemiology Biomarkers & Prevention 2016 cited by 178

  15. Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer

    Authors: , , , , - JCO Clinical Cancer Informatics 2019 cited by 77

  16. Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

    Authors: , , , , , , , - Journal of Clinical Oncology 2016 cited by 249

  17. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA

    Authors: , , , , , , , - PharmacoEconomics 2022 cited by 40

  18. Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States

    Authors: , , , , , , , - Journal of Medical Economics 2018 cited by 113

  19. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance

    Authors: , , , , , - Blood Advances 2022 cited by 92

  20. Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries

    Authors: , , , , , - Blood Advances 2023 cited by 72

  21. Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

    Authors: , , , , , , - Diabetes Care 1999 cited by 1,069

  22. Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement

    Authors: , , , , , , - Journal of Comparative Effectiveness Research 2012 cited by 371

  23. Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials

    Authors: , , , , , , - JNCI Journal of the National Cancer Institute 2014 cited by 232

  24. The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making

    Authors: , , , , - The Breast 2021 cited by 34